Genomics and Epigenomics of the Elderly Response to Pneumococcal Vaccines
Demographics (3)
- AGE - Subject age at enrollment (phv00483201.v2.p1)
- SEX - Self-reported sex (phv00483198.v2.p1)
- SEX - Self-reported sex (phv00483194.v2.p1)
Race and Ethnicity (2)
- ETHNICITY - Self-reported ethnicity (phv00483200.v2.p1)
- RACE - Self-reported race (phv00483199.v2.p1)
Other (19)
- ANALYTE_TYPE - Analyte Type (phv00483207.v2.p1)
- BASELINE - Subject participated in baseline visit 7 days prior to vaccination (phv00483202.v2.p1)
- BODY_SITE - Body site where sample was collected (phv00483206.v2.p1)
- CONSENT - Consent group as determined by DAC (phv00483193.v2.p1)
- DAY1 - Subject visit 1 day after vaccination (phv00495351.v1.p1)
- DAY10 - Subject visit 10 days after vaccination (phv00495352.v1.p1)
- DAY60 - Subject visit 60 days after vaccination (phv00495353.v1.p1)
- HISTOLOGICAL_TYPE - Cell type (phv00483209.v2.p1)
- IS_TUMOR - Tumor status (phv00483208.v2.p1)
- PAPER_METHOD_ID - ID used in the ATAC-Doublet Methodology paper (phv00483204.v2.p1)
- PAPER_METHOD_PRESENCE - Presence of the Subject in the ATAC-Doublet Methodology paper (phv00483203.v2.p1)
- PAPER_VAX_PRESENCE - Presence of the Subject in the pneumococcal vaccine paper (phv00495354.v1.p1)
- SAMPLE_ID - Sample ID (phv00483205.v2.p1)
- SAMPLE_ID - Sample ID (phv00483196.v2.p1)
- SEQUENCING_TYPE - Sequencing type on the sample (phv00483210.v2.p1)
- SUBJECT_ID - Subject ID (phv00483197.v2.p1)
- SUBJECT_ID - Subject ID (phv00483192.v2.p1)
- SUBJECT_ID - Subject ID (phv00483195.v2.p1)
- VACCINE - Innoculation of Prevnar or Pneumonax on day 0 (phv00495350.v1.p1)